Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis
Haldar, J.P.; Ghose, S.; Saha, K.C.; Ghose, A.C.
Infection and immunity 42(2): 702-707
1983
ISSN/ISBN: 0019-9567
PMID: 6642649
Accession: 001169629
Indian kala azar (KA) and post-kala azar dermal leishmaniasis, cell-mediated immune (CMI) status determined by in vitro lymphocyte transformation experiments and by in vivo skin testing, results show impairment of CMI response in active KA which appears to be more specific to leishmania than generalized in nature, restoration of specific T-cell responsiveness was aided by antileishmanial drug therapy which resulted in reduction of antigenic load by parasite destruction and concomitant decrease in circulating antibody levels, particularly that of IgG class
PDF emailed within 1 workday: $29.90
Related References
Neogy, A.B.; Nandy, A.; Ghosh Dastidar, B.; Chowdhury, A.B. 1988: Modulation of the cell-mediated immune response in kala-azar and post-kala-azar dermal leishmaniasis in relation to chemotherapy Annals of Tropical Medicine and Parasitology 82(1): 27-34Bray, R.S.; Ashford, R.W.; Mukherjee, A.M.; Sen Gupta, P.C. 1973: Studies on the immunology and serology of leishmaniasis. IX. Serological investigation of the parasites of Indian kala-azar and Indian post-kala-azar dermal leishmaniasis Transactions of the Royal Society of Tropical Medicine and Hygiene 67(1): 125-129
Ghosh, A.K.; Dasgupta, S.; Ghose, A.C. 1995: Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis Clinical and Diagnostic Laboratory Immunology 2(3): 291-296
Zijlstra, E.E.; Alves, F.; Rijal, S.; Arana, B.; Alvar, J. 2017: Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme Plos Neglected Tropical Diseases 11(11): E0005877
Nandy, A.; Neogy, A.; Ghosh Dastidar, B.; Sarkar, M.; Mallick, K.K.; Chowdhury, A.B. 1983: Immune response and drug response in kala-azar and post-kala-azar dermal leishmaniasis Proceedings of the Indo UK Workshop on leishmaniasis, Rajendra Memorial Research Institute for Medical Sciences ICMR, Patna, 6-10 December 1982: 161-170
Molina, R.; Ghosh, D.; Carrillo, E.; Monnerat, Séverine.; Bern, C.; Mondal, D.; Alvar, J. 2017: Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 65(1): 150-153
Saha, S.; Mondal, S.; Ravindran, R.; Bhowmick, S.; Modak, D.; Mallick, S.; Rahman, M.; Kar, S.; Goswami, R.; Guha, S.K.; Pramanik, N.; Saha, B.; Ali, N. 2007: Il-10- and Tgf--Mediated Susceptibility in Kala-azar and Post-kala-azar Dermal Leishmaniasis: The Significance of Amphotericin B in the Control of Leishmania donovani Infection in India The Journal of Immunology 179(8): 5592-5603
Saha, S.; Mondal, S.; Ravindran, R.; Bhowmick, S.; Modak, D.; Mallick, S.; Rahman, M.; Kar, S.; Goswami, R.; Guha, S.Kamal.; Pramanik, N.; Saha, B.; Ali, N. 2007: IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India Journal of Immunology 179(8): 5592-5603
Thakur, C.P. 1984: Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis) Transactions of the Royal Society of Tropical Medicine and Hygiene 78(3): 391-398
Salih, M.A.M.; Fakiola, M.; Abdelraheem, M.H.; Younis, B.M.; Musa, A.M.; ElHassan, A.M.; Blackwell, J.M.; Ibrahim, M.E.; Mohamed, H.S. 2014: Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients Bmc Infectious Diseases 14: 662
Sultana, A.; Zakaria, S.M.; Bhuiyan, S.I.; Habib, A.; Dey, S.K.; Rahman, M.; Basher, A. 2012: Spectrum of skin lesions of post-kala-azar dermal leishmaniasis in kala-azar endemic areas of Bangladesh Mymensingh Medical Journal: Mmj 21(3): 529-532
Sreenivas, G.; Raju, B.V.Subba.; Singh, R.; Selvapandiyan, A.; Duncan, R.; Sarkar, D.; Nakhasi, H.L.; Salotra, P. 2004: DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal leishmaniasis in humans Journal of Clinical Microbiology 42(4): 1739-1741
Addy, M.; Nandy, A. 1992: Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas? Bulletin of the World Health Organization 70(3): 341-346
Sen, A.; Mukerjee, S. 1961: Observation on antigenic differentiation of leishmania parasites of kala-azar and post-kala-azar dermal leishmaniasis Annals of Biochemistry and Experimental Medicine 21: 105-108
Islam, S. 2019: AmBisome for Kala-azar and Post-kala-azar Dermal Leishmaniasis: An Essential Option but not a Universal Solution Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 69(1): 189
el-Masum, M.A.; Evans, D.A. 1995: Characterization of Leishmania isolated from patients with kala-azar and post kala-azar dermal leishmaniasis in Bangladesh Transactions of the Royal Society of Tropical Medicine and Hygiene 89(3): 331-332
Thakur, C.P.; Kumar, K. 1992: Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes Annals of Tropical Medicine and Parasitology 86(4): 355-359
Zijlstra, E.E.; el-Hassan, A.M.; Ismael, A.; Ghalib, H.W. 1994: Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis American Journal of Tropical Medicine and Hygiene 51(6): 826-836
Mondal, D.; Hasnain, M.G.; Hossain, M.S.; Ghosh, D.; Ghosh, P.; Hossain, H.; Baker, J.; Nath, R.; Haque, R.; Matlashewski, G.; Hamano, S. 2016: Study on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniasis: an open clinical trial and case-control study protocol Bmj Open 6(5): E010050
Salotra, P.; Sreenivas, G.; Pogue, G.P.; Lee, N.; Nakhasi, H.L.; Ramesh, V.; Negi, N.S. 2001: Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis Journal of Clinical Microbiology 39(3): 849-854